IDH2 and cancer: Similar pseudohypoxic conditions may also prevail due to the accumulation of competitive antagonist 2-hydroxyglutarate (D-2HG) in IDH2 mutant cancers and in acidic pH, which enhances the production of L-2HG via the noncanonical activity of lactate dehydrogenase [112].